S. Pampanelli

发表

Mechanisms of Insulin Resistance After Insulin-Induced Hypoglycemia in Humans: The Role of Lipolysis

P. Lucidi, P. Rossetti, F. Porcellati, 2010, Diabetes.

Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.

P. Brunetti, S. Pampanelli, G. Perriello, 1993, The Journal of clinical investigation.

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

P. Brunetti, F. Porcellati, S. Pampanelli, 2000, Diabetes.

Long-Term Intensive Therapy of IDDM Patients With Clinically Overt Autonomic Neuropathy: Effects on Hypoglycemia Awareness and Counterregulation

P. Brunetti, F. Porcellati, S. Pampanelli, 1997, Diabetes.

Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM

P. De Feo, P. Brunetti, S. Pampanelli, 1994, Diabetologia.

Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.

E. Volpi, P. Brunetti, S. Pampanelli, 1995, The Journal of clinical endocrinology and metabolism.

Effects of Recent, Short-Term Hyperglycemia on Responses to Hypoglycemia in Humans: Relevance to the Pathogenesis of Hypoglycemia Unawareness and Hyperglycemia-Induced Insulin Resistance

P. Brunetti, S. Pampanelli, G. Bolli, 1995, Diabetes.

Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans

P. Brunetti, S. Pampanelli, C. Fanelli, 1993, Diabetologia.

Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double‐blind and cross‐over trial

D. Cucinotta, A. Avogaro, F. Porcellati, 2005, Diabetic medicine : a journal of the British Diabetic Association.

Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating

S. Pampanelli, C. Fanelli, G. Colleluori, 2022, Journal of Diabetes & Metabolic Disorders.

Mechanisms of Arterial Hypotension After Therapeutic Dose of Subcutaneous Insulin in Diabetic Autonomic Neuropathy

P. Brunetti, F. Porcellati, S. Pampanelli, 1993, Diabetes.

Effects of the Short-Acting Insulin Analog [Lys(B28),Pro(B29)] on Postprandial Blood Glucose Control in IDDM

P. Brunetti, S. Pampanelli, G. Perriello, 1996, Diabetes Care.

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

P. Brunetti, S. Pampanelli, E. Torlone, 1999, Diabetes care.

Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function

P. Brunetti, S. Pampanelli, G. Bolli, 1995, Diabetes Care.

Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating

S. Pampanelli, C. Fanelli, G. Colleluori, 2022, Journal of Diabetes & Metabolic Disorders.

Long-term effects of pioglitazone versus gliclazide on hepatic and humoral coagulation factors in patients with type 2 diabetes

S. Mariz, P. Brunetti, S. Pampanelli, 2007, Diabetes & vascular disease research.

Evidence of Increased Systemic Glucose Production and Gluconeogenesis in an Early Stage of NIDDM

E. Volpi, P. Brunetti, S. Pampanelli, 1997, Diabetes.

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM RID=""ID="" Abbreviations: HI, Human insulin; MI, monomeric insulin; NEFA, non-esterified fatty acid; HGO, hepatic glucose production rate;

P. Brunetti, S. Pampanelli, C. Fanelli, 1994 .

Brief elevation of hepatic enzymes due to liver ischemia in anorexia nervosa

S. Pampanelli, F. Santeusanio, F. Giordano, 2010, Eating and weight disorders : EWD.

Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM

Paolo Brunetti, P. Brunetti, F. Porcellati, 1993, Diabetes.

Factors affecting dropout in outpatient eating disorder treatment

R. Quartesan, S. Pampanelli, G. Perriello, 2006, Eating and weight disorders : EWD.

Contribution of Autonomic Neuropathy to Reduced Plasma Adrenaline Responses to Hypoglycemia in IDDM: Evidence for a Nonselective Defect

P. Brunetti, S. Pampanelli, G. Bolli, 1997, Diabetes.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Insulin therapy and hypoglycaemia: the size of the problem

F. Porcellati, S. Pampanelli, G. Bolli, 2004, Diabetes/metabolism research and reviews.

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

Paolo Rossetti, P. Rossetti, F. Porcellati, 2003, Diabetes care.

Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulin

P. Rossetti, F. Porcellati, S. Pampanelli, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

P. Brunetti, S. Pampanelli, G. Bolli, 1999, Diabetes care.

Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

P. Brunetti, S. Pampanelli, G. Bolli, 1994, Diabetologia.

Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans

P. Brunetti, S. Pampanelli, G. Bolli, 1994, Diabetologia.

Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes

P. Brunetti, S. Pampanelli, G. Perriello, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans.

P. Rossetti, F. Porcellati, S. Pampanelli, 2003, Diabetes.

Use of the short‐acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time‐interval injection‐meal

P. Brunetti, S. Pampanelli, G. Perriello, 1998, Diabetic medicine : a journal of the British Diabetic Association.

Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state

P. Rossetti, F. Porcellati, S. Pampanelli, 2002, Diabetologia.

Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia

P. Lucidi, P. Rossetti, F. Porcellati, 2007, Diabetologia.

Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control

P. Brunetti, P. Rossetti, F. Porcellati, 2002, Annals of Internal Medicine.

Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia

S. Pampanelli, G. Bolli, C. Fanelli, 1996, Diabetologia.